admin

When:Thursday, December 13, 20187:00 p.m. – 10:00 p.m. EST

Where:VisArts Rockville155 Gibbs StreetRockville, MD  20850United States

The HERstory Gala is the premier event for our chapter and supporters. This elegant event attracts men and women from industry, government, non-profits, and academia from across the Capital Region Metro Area and provides unique opportunities to meet with some of the region’s most successful women. This event is focused on highlighting women trailblazers in the life sciences who have made a significant impact in the region during the year. Ticket price includes open bar, cocktail reception, seated 3-course dinner, and access to biotech industry leaders in the Capital Region.

Only 7 percent of patients live five years after diagnosis of pancreatic cancer, the lowest rate for any cancer, according to the American Cancer Society. Elliot K. Fishman, MD, a researcher and radiologist at Johns Hopkins, is on the forefront of trying to change this statistic, and he’s using artificial intelligence to do it.

The Food and Drug Administration approved the first-ever generic version of EpiPen Thursday — a move the agency says could help lower costs for the drug, which can carry a price tag of more than $600.

Does your small business need assistance in commercializing its HHS SBIR/STTR-funded technology? Was that technology developed with a Phase II HHS SBIR/STTR award that was active at any time between August 2013 and August 2018? (Your company does not need to have a currently active award as any HHS Phase II SBIR/STTR award active in the last 5 years would qualify.)

If your answers to both these questions is “Yes,” then your company should consider applying to the NIH Commercialization Accelerator Program (CAP).

Companies are invited to apply online exit disclaimer icon . Due to popular demand, the deadline for submissions has now been extended to August 23, 2018 11:59pm (PDT). Selected companies will be notified in early September 2018.

Maryland biotechnology firms Profectus BioSciences Inc. and Emergent BioSolutions Inc. will receive up to $36 million to develop and manufacture a new vaccine against a type of virus that causes hemorrhagic fever.

This networking event is for BioTech Professionals in the BioHealth Capital Region. We encourage all professionals, post-docs and scientist to attend – it is a great opportunity to get to know others who are working in science in our region.

This free industry wide event will include music, games, hors d’oeuvres, drinks.

Listen to, network with the hottest startup CXOs in the biohealth capital region at our first in a series of four annual meetups around the Capital Beltway on “OMICS, Digital Health and Precision Medicine Data Science” Panel discussion with refreshments, drinks and networking

Meetup #1: Digital OMICS Innovators Meetup. September 20, 2018, Thursday; 5:00-8:00PM

Johns Hopkins University Montgomery County Campus 9605 Medical Center Dr, Rm 121, Rockville, MD 20850

A Harvard scientist thinks he’s reached a new milestone: a genetic test that helps identify people who are at high risk of having a heart attack. Can he convince doctors to use it?